The mucopolysaccharidosis market is witnessing a surge in innovation, driven by cutting-edge gene therapies, enzyme replacement treatments, and novel drug developments. The market is poised for ...

Hematopoietic stem cell transplantation (HSCT) is a vital treatment for both malignant and non-malignant disorders in pediatric patients.

A new study from the Hong Kong Children's Hospital reveals critical insights into the infection risks associated with ...

Researchers find that certain antioxidant enzymes, called selenoproteins, significantly contribute to fighting cell aging. The team used a gene knockout mouse model to help them study the effects of ...

Immunocompromised patients undergoing hematopoietic stem cell transplants (HSCTs) who have a reported penicillin allergy should be evaluated as the allergy label limits access to preferred antibiotics ...

Omeros Corporation (Nasdaq: OMER) today announced two presentations that will be featured at the 2025 Tandem Meetings – the ...

Elixirgen Therapeutics, Inc. is a clinical-stage biotechnology company focused on the treatment of rare diseases and aging-associated diseases using its ZSCAN4 technology and mRNA platform ...

Omeros Corporation today announced the availability on its website of materials accompanying two presentations given at the 2025 Tandem Meetings ? the Transplantation & Cellular Therapy Meetings of ...

Rocket Pharmaceuticals, Inc.'s innovative therapies show promise after FDA setbacks. With potential $1B+ markets, RCKT offers ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.